Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,023 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma

NCT03538314

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: John Wayne Cancer Center Santa Monica, California, United States

University of Iowa Carver College of Medicine Iowa City, Iowa, United States

St. Luke's University Health Network Easton, Pennsylvania, United States

University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

CT Perfusion in the Prognostication of Cerebral High Grade Glioma

NCT01923922

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: QE II Health Sciences Centre Halifax, Nova Scotia, Canada

View Trial Details

Completed

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

NCT00655655

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +70 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Metanephrines in Obstructive Sleep Apnoea

NCT05053685

Conditions: Apnea, Catecholamine; Secretion, Dyssomnias, +16 more
Locations: Changi General Hospital Singapore

View Trial Details

Completed

Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)

NCT00809588

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

NCT06562621

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
Locations: Beijing Tiantan Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

18F-FET PET/CT in the Management of Glioma

NCT06563024

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Hualien Tzu Chi Hospital Hualien City, Taiwan

View Trial Details

Completed

Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

NCT04492163

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Nemocnice Na Homolce Prague, Czechia

View Trial Details

Completed

BESPOKE Study of ctDNA Guided Immunotherapy

NCT04761783

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +28 more
Locations: Natera San Carlos, California, United States

View Trial Details

Completed

Docetaxel With or Without AZD6244 in Melanoma

NCT01256359

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Churchill Hospital Oxford, Oxfordshire, United Kingdom

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions